Search Results 741-750 of 25516 for treatment resistant depression
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this two-stage Phase 2 study is to assess the clinical response (Complete Remission) to FLAM compared to AM treatment in refractory or relapsed ...
When someone you care ... Fewer symptoms of depression. Lower blood ... Make your tax-deductible gift and be part of the cutting-edge research and care that's ...
Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia. Print details. Share; Facebook · Twitter.
Clinical Trials · Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors.
Participation eligibility · Child, age 6 to 16 (inclusive) · Has anxiety, depression, or obsessive-compulsive disorder · Receiving treatment in an outpatient ...
Pancreatic cancer remains a challenge to treat, but newer combination therapies are modestly improving survival rates. Cancer surgeon Dr. Mark Truty discusses ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.
Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma · More about research at ...
The purpose of this study is to determine the effectiveness of three doses of orvepitant, taken once a day, in the treatment of chronic refractory cough.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.